Institutions such as AIEA (Atomic Energy international Agency) and IARC (International Agency for Research on Cancer), a body of the World Health Organization headquartered in France, allocated funds to A.C.Camargo for the development of new technologies for cancer diagnosis and treatment.
MD Anderson Cancer Center, main Oncology Treatment Center of the world, established a partnership with A.C.Camargo and the Hospital became a Sister Institution.
Hospital A.C.Camargo is, since 2007, responsible for the National Institute for Oncogenomics Science and Technology (INCITO), with the following international partners: M.D.Anderson Cancer Center, Houston, United States; International Agency for Research on Cancer, Lyon, France;, McGill University, Montreal, Canada;, University of Heidelberg, Heidelberg, Germany; Memorial Sloan-Kettering Cancer Center, New York, United States. Virginia Bioinformatics Institute, Virginia, United States, Grupo Colaborativo Uruguayo - Investigation de Afecciones Oncológicas Hereditárias, Montevideo, Uruguay, Hospital Italiano, Buenos Aires, Argentina and Instituto Nacional de Enfermedades Neoplasicas, Peru.
Also in the research ambit, Hospital A.C.Camargo shares its Tumor Bank with Hospital de Câncer of the municipality of Barretos. Together, these institutions are responsible for the largest tumoral tissue collection for cancer research of Latin America. Another important partnership in cancer collaboration projects is that with Instituto do Câncer de São Paulo (ICESP), linked to Universidade de São Paulo.